The United Kingdom indefinitely extended a ban on puberty blockers for people younger than 18, barring medication prescriptions used to treat gender dysphoria, the government announced this week.

and also risks to children and young people associated with accessing GnRH agonists via alternative routes. Dr Hilary Cass, author of the Independent review of gender identity services for children ...

and also risks to children and young people associated with accessing GnRH agonists via alternative routes.” Puberty blockers are medicines that prevent puberty from happening. They work by blocking ...

LONDON — The British government on Wednesday indefinitely banned puberty blockers for children with gender dysphoria after independent experts found there was an unacceptable safety risk in ...

Puberty blockers are to be banned indefinitely in the UK after an expert review warned that the drugs posed an “unacceptable safety risk” to children. The Government said that an independent ...

Puberty blockers for under 18s with gender dysphoria with be banned indefinitely in the UK because of an “unacceptable safety risk”, the Department of Health and Social Care, led by Wes Streeting, has ...

New research into the use of beta agonists released this week raises concerns about the animal health and welfare of feedlot cattle. The peer-reviewed article, while acknowledging “significant ...

Glucagon-like peptide-1 (GLP-1) receptor agonists have quickly become some of the most ubiquitous drugs in the United States. Though they were originally indicated to treat diabetes, and to assist ...

Using clinical information from a large, observational database of over 21,000 people with HD, the UI team found that the use of beta-blocker drugs – commonly used to treat heart and blood ...